Not first‐line antihypertensive agents, but still effective-The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis

• Päätekijät: András Érszegi (Tekijä), Réka Viola (Tekijä), Muh Akbar Bahar (Tekijä), Barbara Tóth (Tekijä), Imola Fejes (Tekijä), Anna Vágvölgyi (Tekijä), Dezső Csupor (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wiley, 2024-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Cardiovascular disorders are the leading cause of death in the world. Many organ diseases (kidney, heart, and brain) are substantially more prone to develop in people with hypertension. In the treatment of hypertension, first‐line medications are recommended, while imidazoline receptor agon...